Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Link to relevant study record(s)

Description of key information

The substance (an organic salt) will be absorbed and distributed systemically when administered orally based on histopathological changes in the kidneys of high dose animals. The substance shows an increase of chromosomal aberrations in an in-vitro test without metabolic activation but not with metabolic activation and not in the in-vivo test. Apparently, its metabolites are not active from the genotoxic point of view.
The high water solubility and small moleculare weights of the ions suggest that the substance should be systemically available via pulmonary absorption, but inhalation exposure may be limited by particle size. The low log Pow value and the ionic structure suggest that the substance will not bioaccumulate. Dermal absorption is considered to be very low based on results of dermal toxicity tests (LD50>2000 mg/kg, not irritant to skin (500 mg) nor to eye (100 mg); no sensitisation) indicating, that when applied dermally, the substance is not systemically toxic. The low log Pow value (-2.57 at 22°C) and the ionic structure suggest that the substance is not likely to be sufficiently lipophilic to cross the stratum corneum, therefore dermal absorption is likely to be low.

Key value for chemical safety assessment

Bioaccumulation potential:
no bioaccumulation potential
Absorption rate - oral (%):
100
Absorption rate - dermal (%):
10
Absorption rate - inhalation (%):
100

Additional information